Home Compliance Teva Pharmaceuticals Settles to Pay Over $519 Million in Penalties for Violations... ComplianceFCPANews Teva Pharmaceuticals Settles to Pay Over $519 Million in Penalties for Violations of the Foreign Corrupt Practices Act January 13, 2020 10 Share FacebookLinkedinTwitter Soru Epotok | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Sanctions Compliance: Understanding the Red Lines of Enforcement (Part I of II) Compliance State False Claims and AKS Statutes Keep Case Alive in 2nd Circuit Compliance SEC Modernizes Data Protection Rules for Safeguarding Customer Information